)
Visual
test
Mayne Pharma Group
Mayne Pharma Group (MYX) investor relations material
Mayne Pharma Group AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary28 Jan, 2026
Opening remarks and agenda
Meeting opened with acknowledgment of the hybrid format, procedural guidance, and was chaired by Professor Bruce Robinson at 10:00am Melbourne time.
Board and executive introductions included recognition of outgoing directors, the company's auditor, and outlined the agenda: Chair's report, CFO's business update, Q&A, and voting on resolutions.
Financial performance review
FY 2025 revenue grew 5% to AUD 408.1 million, gross margin expanded to 60.6%, and underlying EBITDA more than doubled to AUD 47 million.
Operating cash flow from continuing operations improved to AUD 45.4 million, reflecting tighter cost control and a more profitable product mix, though cash and marketable securities declined to AUD 100.4 million.
1H FY 2026 unaudited revenue was AUD 212.1 million, with gross margin up to 66%; underlying EBITDA was AUD 28.6 million, down 8% due to increased investment.
Women's Health segment revenue rose 25%, with NEXTSTELLIS showing strong demand; dermatology margins improved despite generic competition, and international segment growth driven by new launches and partnerships.
Segment highlights: Women's Health revenue up 2%, Dermatology gross margin up 12%, International gross profit up 6%.
Board and executive committee updates
Frank Condella retired as Chair in January 2026; Anne Lockwood and Pat Blake to retire after mid-year results.
Board comprised of the Chair, several non-executive directors, CEO & Managing Director, and CFO, with introductions provided at the start.
Board priorities remain focused on execution, earnings quality, disciplined capital allocation, and strategic initiatives.
Ann Custin and David Petrie stood for re-election, highlighting their experience and commitment.
How does Cosette outcome shape M&A strategy?
Detail plans to mitigate royalty burden.
How will disintermediation and new coverage drive growth?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- TMCV
Q2 FY26 delivered double-digit margin growth, record cash flow, and strong market momentum. - DANSKE
Record profit, strong credit quality, and 100% payout; 2026 outlook remains positive. - GREENPLY
Q3 FY26 delivered strong revenue growth but lower profit, with major MDF expansion announced. - KRO
Q1 2025 net income surged to $18.1M on higher TiO2 sales, improved margins, and LPC integration. - WALL
Profit after tax more than tripled to SEK 2,564 million, with net asset value per share up 8%. - TMCVQ3 FY26 delivered 17% revenue growth, 12.7% EBITDA margin, and strong cash flow.
- SHL
Imaging and therapy growth drove 3.8% Q1 revenue; 2026 outlook and EPS guidance confirmed. - SAAB
Record order backlog and double-digit growth across all segments fueled strong 2025 results. - KROQ3 2025 net loss of $37M reflects lower TiO2 prices, weak demand, and higher costs.
- YATHARTH
Strong revenue and profit growth, major capital deployment, and new hospital acquisition mark the quarter.
Next Mayne Pharma Group earnings date
H1 202624 Feb, 2026
Mayne Pharma Group
Next Mayne Pharma Group earnings date
H1 202624 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Mayne Pharma Group Limited is an Australian pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic pharmaceutical products. The company’s portfolio spans various therapeutic areas, including women’s health, dermatology, and pain management, with products available in oral, topical, and injectable forms. Mayne Pharma operates manufacturing facilities in Australia and the United States, and its services include contract development and manufacturing for other pharmaceutical companies. The company is headquartered in Salisbury, South Australia, and its shares are listed on the Australian Securities Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage